Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: oxadiazolyl ketones.
Koo, K.D., Kim, M.J., Kim, S., Kim, K.H., Hong, S.Y., Hur, G.C., Yim, H.J., Kim, G.T., Han, H.O., Kwon, O.H., Kwon, T.S., Koh, J.S., Lee, C.S.(2007) Bioorg Med Chem Lett 17: 4167-4172
- PubMed: 17544668 
- DOI: https://doi.org/10.1016/j.bmcl.2007.05.046
- Primary Citation of Related Structures:  
2QKY - PubMed Abstract: 
Synthesis of a novel series of DPPIV inhibitors with 1,2,4- and 1,3,4-oxadiazolyl ketone derivatives and its structure-activity relationships are discussed. Compound 18h showed good inhibitory activity against DPPIV and favorable pharmacokinetic properties. In vivo pharmacodynamic efficacy and co-crystal structure of compound 18h with DPPIV is also described.
Organizational Affiliation: 
LG Life Sciences, Ltd/R&D Park, 104-1 Munji-dong, Yuseong-gu, Daejeon 305-380, Republic of Korea.